In a move to address the ongoing concerns within the Korean medical community regarding the expansion of the medical school admission quota, President Yoon Suk Yeol met with healthcare professionals on Monday, urging them to consider future generations and engage in dialogue without insisting on mai
D&D Pharmatech, a Korean biotech company, said it expanded its collaboration with the U.S.-based Metsera for new treatments. This expansion includes amendments to a previously established agreement for an oral obesity treatment and the initiation of a new global technology transfer agreement for an
Lunit said it signed contracts to supply its AI solutions to France's largest teleradiology network, TeleDiag, and the Central Center of the Portuguese Cancer League (Liga Portuguesa Contra o Cancro, LPCC), a prominent nonprofit organization in Portugal.Lunit has recently secured a contract with Tel
Celltrion officially launched Zymfentra, also known as Remsima SC in Europe, in the U.S., last Friday.Zymfentra is the world's only subcutaneous (SC) form of infliximab, having received FDA approval in October of the previous year. Under the approval, the drug can treat moderate to severe active ulc
Lee Jin-a was appointed as the first Korean President and CEO of Bayer Korea in October of last year, a noteworthy event in the company's history spanning nearly 70 years. This appointment highlights the changing dynamics and strategic priorities of the Korean healthcare industry within the multinat
In a show of international solidarity, the Medical Women's International Association (MWIA) has issued a strong statement in support of the Korean Medical Women's Association (KMWA) following a gender-biased statement made by a high-level Korean government official in Seoul, Korea, this past Februar
The Korea Health Industry Development Institute (KHIDI) has inked a memorandum of understanding (MOU) with the Medical Research Council (MRC), part of the U.K.’s Research and Innovation (UKRI).UKRI, overseeing an impressive budget of approximately 14 trillion won ($11 billion) as of last year, funct
Bayer Korea's Kerendia (ingredient: finerenone), a novel non-steroidal mineralocorticoid receptor antagonist (MRA), is garnering significant attention from local physicians as a potential game-changer in the treatment of chronic kidney disease (CKD) associated with type 2 diabetes.The drug, which ta
Sales of Korean erectile dysfunction treatments hit all-time high in 2023 for the third consecutive year, with local pharmaceutical companies having around 90 percent of the market share.Leading the charge were Korean generic drugs like Hanmi Pharm's Palpal and Gugu, and Chong Kun Dang's Sendom, sig
In a move reflecting the intricate dance between branding, legal challenges, and market positioning, two Korean biotech companies, LegoChem Biosciences and Helixmith, have announced changes to their corporate identities.LegoChem Biosciences will soon undergo a transformation to LigaChem Biosciences,
A collaborative research team from Severance Hospital and the Korea Advanced Institute of Science and Technology (KAIST) has uncovered mechanisms that contribute to the early development of resistance to chemotherapy in pancreatic cancer treatment.Despite advances in the survival rates of other intr
Obesity is becoming a serious problem in Korea.A recent statistical report published by the Ministry of Health and Welfare and the Korea Health Promotion Institute on Monday highlighted a worrying obesity trend in the aftermath of the Covid-19 pandemic, showing a sharp rise in obesity rates across a
Lunit said it has received the first-phase approval from the New Zealand High Court for its acquisition of Volpara Health Technologies.Volpara, established in 2009 in Wellington, New Zealand, specializes in AI-based breast cancer screening solutions. It has supplied its technology to over 2,000 medi
Liveome, an affiliate of Medytox, said it completed the phase 1 clinical trial in Australia for its gene-recombinant microbiome drug, LIV001.The drug is being developed as a treatment for inflammatory bowel disease, a chronic immune disorder that has been challenging to manage with existing therapie
A team of researchers from Yonsei University, Severance Hospital, and Gangnam Severance Hospital has developed a high-safety, liquid metal-based soft artificial retina.This innovative technology promises to restore vision to patients blinded by retinal diseases, including retinitis pigmentosa and ma
Korean pharmaceutical and biotechnology companies are set to present their latest studies at the American Association for Cancer Research (AACR) Annual Meeting 2024.The AACR meeting, established in 1907 and regarded as one of the world's top three cancer conferences alongside those of the American S
The National Cancer Center (NCC) said it has discovered a biomarker that can distinguish pancreatic cancer patients from healthy individuals "with 100 percent accuracy" and has licensed out the biomarker to New Cancer Cure Bio.The biomarkers X-100 and X-99 have shown the capability to accurately dif
ST Pharm and LegoChem Biosciences have entered into a contract for joint research and manufacturing of antibody drug conjugate (ADC) linkers.Under the accord, ST Pharm plans to provide contract development and manufacturing organization (CDMO) services covering the entire production process based on
Celltrion said it has completed its application to the U.S. FDA for the approval of CT-P39, a biosimilar referencing Xolair (ingredient: omalizumab). Xolair was developed by Genentech and Novartis for the treatment of allergic asthma, chronic rhinosinusitis with nasal polyposis, and chronic idiopath
Olympus, a Japan-based global medical device company, has decided to terminate its acquisition of Taewoong Medical, a Korea-based specialist in gastrointestinal stents, just two months after announcing the deal in January.The decision comes after Olympus discovered issues related to data integrity i